Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease.

Nature aging·2026
Same author

The myth of digital biomarkers in Alzheimer's disease: how to make them a reality.

Current opinion in psychiatry·2026
Same author

A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia.

Nature medicine·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Farhad Imam1

  • 1Gates Ventures, Seattle, WA, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
PubMed
Summary

The Global Research and Imaging Platform (GRIP) offers a secure, cloud-based solution to accelerate dementia and Alzheimer's research. This collaborative platform provides multimodal data analysis tools, aiming to speed up discoveries for millions affected by these diseases.

Area of Science:

  • Neuroscience
  • Bioinformatics
  • Data Science

Background:

  • The dementia research community faces a critical gap in end-to-end, multimodal collaborative data analysis platforms.
  • Vast amounts of neurodegenerative disease data offer potential for groundbreaking insights into Alzheimer's and dementia.
  • The Global Research and Imaging Platform (GRIP) addresses these challenges with an open-access, secure cloud environment.

Purpose of the Study:

  • To provide a collaborative, secure, and user-friendly cloud platform for dementia research.
  • To enhance researcher productivity and optimize spending through open-access tools.
  • To facilitate large-scale analyses and collaborations for faster scientific breakthroughs.

Main Methods:

  • GRIP is built on a modular infrastructure supporting biomedical imaging research.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702
  • It comprises five key components: discovery, access requests, data sharing, workspaces, and workflows.
  • GRIP has partnered with 11 ADRC institutions and global collaborators to develop 17 modular tools for integrated data analysis.

    • Main Results:

    • GRIP offers over a dozen analysis workflows for neuroimaging, digital voice, and omics data.
    • The platform provides a streamlined, secure cloud environment for individual researchers and international consortia.
    • Scheduled for launch in Q2 2025, GRIP aims to support advanced dementia research.

    Conclusions:

    • GRIP is designed to save researchers and funders time and money.
    • The platform facilitates cutting-edge research previously hindered by infrastructure limitations.
    • By enabling new research avenues, GRIP aims to improve outcomes for individuals with Alzheimer's and related dementias.